Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Punicic acid is a conjugated linolenic acid primarily found in pomegranate seed oil. Its use for supporting or treating metabolic syndrome is based on emerging scientific research, though evidence from human studies remains limited. Preclinical studies, particularly in animal models, suggest that punicic acid may improve parameters related to metabolic syndrome, such as insulin sensitivity, lipid profiles, and inflammation. For example, several rodent studies have demonstrated that supplementation with punicic acid or pomegranate seed oil can reduce triglyceride levels, improve glucose tolerance, and attenuate weight gain associated with high-fat diets. These effects are thought to be mediated by modulation of lipid metabolism, anti-inflammatory activity, and antioxidant properties. However, clinical evidence in humans is sparse. Some small-scale studies using pomegranate seed oil (rich in punicic acid) in people with obesity or metabolic disturbances have hinted at potential improvements in lipid profiles and markers of inflammation, but results are inconsistent and sample sizes are often too small to draw robust conclusions. No major clinical trials have directly tested purified punicic acid for metabolic syndrome. As such, while there is a scientific rationale and preclinical support for its use, high-quality human research is needed before punicic acid can be recommended with confidence for metabolic syndrome.

More about punicic acid
More about Metabolic Syndrome

Other ingredients used for Metabolic Syndrome

Other health conditions supported by punicic acid

Products containing punicic acid